CN Patent

CN121079106A — 一种靶向LPA的dsRNA及其应用

Assigned to Shanghai Tuojie Biomedical Technology Co ltd · Expires 2025-12-05 · 0y expired

What this patent protects

一种靶向LPA的dsRNA及其应用。一种靶向LPA的双链核糖核酸(dsRNA)及制备方法。包含该dsRNA的药物组合物、细胞或试剂盒。dsRNA可以干扰LPA的表达，预防和/或治疗相关疾病。

USPTO Abstract

一种靶向LPA的dsRNA及其应用。一种靶向LPA的双链核糖核酸(dsRNA)及制备方法。包含该dsRNA的药物组合物、细胞或试剂盒。dsRNA可以干扰LPA的表达，预防和/或治疗相关疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN121079106A
Jurisdiction
CN
Classification
—
Expires
2025-12-05
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Tuojie Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.